Singapore, 5 September 2026 – Healthcare organisations are adopting specialised artificial intelligence at a faster pace than the wider economy, but the industry still faces a basic investment question: how should it measure whether generative AI delivers durable value? The answer is more complex than counting software licences or minutes saved because clinical outcomes, patient safety and workflow changes can carry greater weight than immediate cost reductions.
Research on the United States market found that 22% of healthcare organisations had implemented domain-specific AI, compared with 9% across the broader economy. Adoption reached 27% among health systems, 18% in outpatient care and 14% among payers. The figures suggest healthcare deployment was about 2.2 times broader than the economy-wide rate, even as the sector continued to confront fragmented data and demanding regulatory requirements.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here

